Cargando…

Characteristics of prevalent and new COPD cases in Greece: the GOLDEN study

BACKGROUND: Greece has one of the highest rates of smoking and chronic obstructive pulmonary disease (COPD) in Europe. AIM: The study aimed to record both the disease characteristics among a sample of Greek COPD patients and the nationwide rates of newly diagnosed COPD cases. METHODS: In this nonint...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitsiki, Eirini, Bania, Eleni, Varounis, Christos, Gourgoulianis, Konstantinos I, Alexopoulos, Evangelos C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516213/
https://www.ncbi.nlm.nih.gov/pubmed/26229456
http://dx.doi.org/10.2147/COPD.S81468
_version_ 1782383032004509696
author Mitsiki, Eirini
Bania, Eleni
Varounis, Christos
Gourgoulianis, Konstantinos I
Alexopoulos, Evangelos C
author_facet Mitsiki, Eirini
Bania, Eleni
Varounis, Christos
Gourgoulianis, Konstantinos I
Alexopoulos, Evangelos C
author_sort Mitsiki, Eirini
collection PubMed
description BACKGROUND: Greece has one of the highest rates of smoking and chronic obstructive pulmonary disease (COPD) in Europe. AIM: The study aimed to record both the disease characteristics among a sample of Greek COPD patients and the nationwide rates of newly diagnosed COPD cases. METHODS: In this noninterventional, epidemiological cross-sectional study, a representative nationwide sample of 45 respiratory centers provided data on the following: 1) the demographic and clinical characteristics of COPD patients and 2) newly diagnosed COPD cases monitored over a period of 6 months by each physician. RESULTS: Data from 6,125 COPD patients were collected. Advanced age (median age: 68 years), male predominance (71.3%), largely overweight status with median body mass index (BMI) =27.5 kg/m(2), high percentage of current and ex-smokers (89.8%), and presence of comorbidities (81.9%) were evident in the sample. According to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2011 criteria, majority of the COPD patients had moderate or severe airflow limitation (61%). Severity of airflow limitation was significantly associated with older age, male sex, obesity, ex-smoking status, and presence of comorbidity (all P-values <0.001). A total of 61.3% of the patients received medication, mostly bronchodilators (64.4%) and fixed-dose combinations of long-acting β(2)-agonists and inhaled corticosteroids (39.9%), while 35.9% reported taking medication on demand. The majority (81.1%) of patients reported a preference for fewer inhalations of their bronchodilator therapy. Based on the mixed-effect Poisson model, the rate of newly diagnosed COPD cases was estimated to be 18.2% (95% confidence interval: 14.9–22.3) per pulmonologist/3 months. Of those newly diagnosed, the majority of patients had mild or moderate airflow limitation (78.2%). CONCLUSION: The Greek Obstructive Lung Disease Epidemiology and health ecoNomics study reflected the real-life profile of COPD patients and provided evidence on the profile of new COPD cases in Greece. Various demographic factors were delineated, which can assist in designing more effective diagnostic and management strategies for COPD in Greece.
format Online
Article
Text
id pubmed-4516213
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-45162132015-07-30 Characteristics of prevalent and new COPD cases in Greece: the GOLDEN study Mitsiki, Eirini Bania, Eleni Varounis, Christos Gourgoulianis, Konstantinos I Alexopoulos, Evangelos C Int J Chron Obstruct Pulmon Dis Original Research BACKGROUND: Greece has one of the highest rates of smoking and chronic obstructive pulmonary disease (COPD) in Europe. AIM: The study aimed to record both the disease characteristics among a sample of Greek COPD patients and the nationwide rates of newly diagnosed COPD cases. METHODS: In this noninterventional, epidemiological cross-sectional study, a representative nationwide sample of 45 respiratory centers provided data on the following: 1) the demographic and clinical characteristics of COPD patients and 2) newly diagnosed COPD cases monitored over a period of 6 months by each physician. RESULTS: Data from 6,125 COPD patients were collected. Advanced age (median age: 68 years), male predominance (71.3%), largely overweight status with median body mass index (BMI) =27.5 kg/m(2), high percentage of current and ex-smokers (89.8%), and presence of comorbidities (81.9%) were evident in the sample. According to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2011 criteria, majority of the COPD patients had moderate or severe airflow limitation (61%). Severity of airflow limitation was significantly associated with older age, male sex, obesity, ex-smoking status, and presence of comorbidity (all P-values <0.001). A total of 61.3% of the patients received medication, mostly bronchodilators (64.4%) and fixed-dose combinations of long-acting β(2)-agonists and inhaled corticosteroids (39.9%), while 35.9% reported taking medication on demand. The majority (81.1%) of patients reported a preference for fewer inhalations of their bronchodilator therapy. Based on the mixed-effect Poisson model, the rate of newly diagnosed COPD cases was estimated to be 18.2% (95% confidence interval: 14.9–22.3) per pulmonologist/3 months. Of those newly diagnosed, the majority of patients had mild or moderate airflow limitation (78.2%). CONCLUSION: The Greek Obstructive Lung Disease Epidemiology and health ecoNomics study reflected the real-life profile of COPD patients and provided evidence on the profile of new COPD cases in Greece. Various demographic factors were delineated, which can assist in designing more effective diagnostic and management strategies for COPD in Greece. Dove Medical Press 2015-07-20 /pmc/articles/PMC4516213/ /pubmed/26229456 http://dx.doi.org/10.2147/COPD.S81468 Text en © 2015 Mitsiki et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Mitsiki, Eirini
Bania, Eleni
Varounis, Christos
Gourgoulianis, Konstantinos I
Alexopoulos, Evangelos C
Characteristics of prevalent and new COPD cases in Greece: the GOLDEN study
title Characteristics of prevalent and new COPD cases in Greece: the GOLDEN study
title_full Characteristics of prevalent and new COPD cases in Greece: the GOLDEN study
title_fullStr Characteristics of prevalent and new COPD cases in Greece: the GOLDEN study
title_full_unstemmed Characteristics of prevalent and new COPD cases in Greece: the GOLDEN study
title_short Characteristics of prevalent and new COPD cases in Greece: the GOLDEN study
title_sort characteristics of prevalent and new copd cases in greece: the golden study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516213/
https://www.ncbi.nlm.nih.gov/pubmed/26229456
http://dx.doi.org/10.2147/COPD.S81468
work_keys_str_mv AT mitsikieirini characteristicsofprevalentandnewcopdcasesingreecethegoldenstudy
AT baniaeleni characteristicsofprevalentandnewcopdcasesingreecethegoldenstudy
AT varounischristos characteristicsofprevalentandnewcopdcasesingreecethegoldenstudy
AT gourgoulianiskonstantinosi characteristicsofprevalentandnewcopdcasesingreecethegoldenstudy
AT alexopoulosevangelosc characteristicsofprevalentandnewcopdcasesingreecethegoldenstudy